Polinsky David bought ERNA
August 31, 2026 · Form 4 insider transaction
Polinsky David bought 5,083 shares of Ernexa Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,083
Price
$0.00
Total value
N/A
InsiderPolinsky David
RoleOfficer
SecurityStock Option (Right to buy)
Transaction codeA: Grant or award
Transaction dateAugust 31, 2026
Filing dateSeptember 1, 2026
Shares owned after5,083
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026.